You are here

  • Home
  • Archive
  • Volume 11, Issue 3
  • QRISK underestimated risk of cardiovascular disease in general practice patients; Framingham score overestimated riskCommentary

Article Text

Article menu
Download PDFPDF
Clinical prediction guide
QRISK underestimated risk of cardiovascular disease in general practice patients; Framingham score overestimated risk

http://dx.doi.org/10.1136/ebn.11.3.91

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    J Hippisley-Cox

    Prof J Hippisley-Cox, University Park, Nottingham, UK; Julia.hippisley-cox@nottingham.ac.uk

    QUESTION

    Does QRISK score predict risk of cardiovascular disease (CVD) in a validation sample of general practice patients? How does it compare with Framingham score?

    METHODS

    Design:

    prospective cohort study.

    Setting:

    2 validation cohorts from general practices in the UK that provided routinely collected clinical data to 1 of 2 research databases (QRESEARCH, n = 160; THIN, n = 274).

    Patients:

    patients who were included in the THIN (n = 1.07 million) or QRESEARCH (n = 0.61 million) databases, were 35–74 years of age (51% women), did not have diabetes or CVD, and were not taking statins at baseline.

    Description of prediction guide:

    QRISK score included traditional risk factors (age, sex, systolic blood pressure, smoking status, and total/high density lipoprotein serum cholesterol ratio) as well as social deprivation …

    View Full Text

    Footnotes

    • Source of funding: no external funding.